Full-Time
Vice President
Translational Immunology
Confirmed live in the last 24 hours
Develops RNA-based medicines and vaccines
Senior, Expert
Cambridge, MA, USA
- Ph.D. in Immunology, Genetics, Bioengineering, or a related field.
- 12 years of postdoctoral experience as well as 7 years within biotechnology/pharmaceutical, including experience performing immuno-oncology research.
- Broad scientific and technical expertise in immunology and immune-oncology, particularly CAR T cells approach.
- Scientific and technical expertise in cell and gene therapy would be a plus.
- Demonstrated ability to lead a team of experienced leaders.
- Experience with writing regulatory documents to support FIH studies.
- Strong interpersonal and presentation skills with good judgment and ability to communicate with a diverse range of individuals.
- Work with the leadership team to provide strategy and vision as well as make decisions that establish objectives for the overall direction for our research.
- Innovate novel scientific projects/platforms for the company.
- Lead research work, including vaccine, immunology, and protein therapeutics/engineering.
- Develop key methods for identification of clinical biomarkers and correlatives including ensuring the appropriate collection, processing, and analysis of clinical samples.
- Motivate and grow research teams to achieve corporate objectives.
- Oversee the development of preclinical IND packages for portfolio products, including nonclinical study reports and regulatory documents.
- Work with the Clinical team to develop target candidate profile and design experiments that support clinical plans.
- Regularly present experimental findings to the leadership team and supervise the team members as they generate, record, and present data.
- Helps draft progress reports, summaries for patent applications and/or scientific publications and provide external representation at conferences.
Orbital Therapeutics is leading the way in RNA-based medical treatments by creating innovative delivery methods and utilizing data science and automation. This focus aligns with treating a range of human diseases in areas such as vaccines, immunomodulation, protein replacement, and regenerative medicine. Working here offers a cutting-edge and collaborative environment dedicated to impactful advancements in healthcare, providing employees with the opportunity to contribute significantly to pioneering medical solutions.
Company Stage
Series A
Total Funding
$320M
Headquarters
Cambridge, Massachusetts
Founded
2022